Catalyst Ortho Names Dr. Miguel Ramirez as Chief Medical Officer

Catalyst OrthoScience, a company focused on shoulder arthroplasty, has appointed Dr. Miguel Ramirez as its new chief medical offer (CMO), effective immediately.

Dr. Ramirez succeeds Catalyst founder Dr. Steven Goldberg, who left his roles as CMO and board member but said he will stay actively engaged with the company.

“It has been an incredible journey to shape Catalyst into what it is today, and I am proud of what we have accomplished together,” said Dr. Goldberg. “I am thrilled to continue contributing to our mission in a new capacity and am excited to welcome Dr. Ramirez. His leadership and expertise will make a significant impact as Catalyst continues to grow.”

Dr. Ramirez is a board-certified orthopedic surgeon who completed his fellowship in shoulder and elbow surgery at MedStar Union Memorial Hospital and is a graduate of Harvard Medical School. He has held the leadership roles of Chairman of the Department of Orthopedic Surgery at OSF St. Francis Medical Center and Assistant Clinical Professor at the University of Illinois College of Medicine.

Throughout his career, Dr. Ramirez contributed to clinical research on shoulder biomechanics and implant design. He’s collaborated with leading orthopedic firms to develop implants and surgical techniques, and been a principal investigator in multiple clinical trials to evaluate emerging orthopedic technologies.

“We are excited to continue working with Dr. Goldberg and privileged to have Dr. Ramirez join the team as we drive the next phase of growth,” said Carl O’Connell, president and CEO of Catalyst OrthoScience. “We have ambitious goals, and Dr. Ramirez’s experience in clinical innovation, ASCs, and healthcare system navigation will be invaluable as we redefine shoulder arthroplasty for surgeons, healthcare facilities, payors, and patients.”

“Catalyst has already made tremendous advancements in orthopedics—I experience it in my practice and with my patients every day,” added Dr. Ramirez. “I am excited to build upon the remarkable foundation established by Dr. Goldberg and the team. With the growing demand for efficient healthcare solutions, increased ASC adoption, and Catalyst’s market positioning, I’m confident that we have the right elements in place for significant impact.”

In October 2024, the company promoted Amy Ables, Ph.D. to the position of chief commercial officer. Dr. Ables joined Catalyst in 2023.